Vontobel Holding Ltd. Neurocrine Biosciences Inc Transaction History

Vontobel Holding Ltd.

  • $27.3 Billion
  • Q4 2024

A detailed history of Vontobel Holding Ltd. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Vontobel Holding Ltd. holds 8,442 shares of NBIX stock, worth $961,121. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,442
Previous 14,590 42.14%
Holding current value
$961,121
Previous $1.68 Million 31.39%
% of portfolio
0.0%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 29, 2025
SELL
$111.62 - $139.44 $686,239 - $857,277
-6,148 Reduced 42.14%
8,442 $1.15 Million
Q3 2024

Oct 15, 2024
BUY
$114.58 - $153.15 $187,796 - $251,012
1,639 Added 12.66%
14,590 $1.68 Million
Q2 2024

Aug 13, 2024
BUY
$130.86 - $143.19 $628,258 - $687,455
4,801 Added 58.91%
12,951 $1.78 Million
Q1 2024

May 10, 2024
BUY
$130.4 - $143.74 $76,414 - $84,231
586 Added 7.75%
8,150 $1.12 Million
Q4 2023

Jun 03, 2024
SELL
$106.07 - $132.76 $251,279 - $314,508
-2,369 Reduced 28.01%
6,089 $802,000
Q4 2023

Jan 29, 2024
SELL
$106.07 - $132.76 $277,585 - $347,432
-2,617 Reduced 25.7%
7,564 $996,000
Q3 2023

Jun 03, 2024
SELL
$94.02 - $117.1 $117,525 - $146,375
-1,250 Reduced 12.88%
8,458 $951,000
Q3 2023

Oct 10, 2023
SELL
$94.02 - $117.1 $117,525 - $146,375
-1,250 Reduced 10.94%
10,181 $1.15 Million
Q2 2023

Jun 03, 2024
SELL
$89.53 - $104.87 $53,270 - $62,397
-595 Reduced 5.78%
9,708 $915,000
Q2 2023

Jul 24, 2023
SELL
$89.53 - $104.87 $53,270 - $62,397
-595 Reduced 4.95%
11,431 $1.08 Million
Q1 2023

Jun 03, 2024
BUY
$94.11 - $123.02 $202,618 - $264,862
2,153 Added 26.42%
10,303 $1.04 Million
Q1 2023

Apr 12, 2023
BUY
$94.11 - $123.02 $828,638 - $1.08 Million
8,805 Added 273.36%
12,026 $1.22 Million
Q4 2022

Feb 14, 2023
SELL
$106.72 - $127.06 $282,167 - $335,946
-2,644 Reduced 45.08%
3,221 $384,000
Q3 2022

Nov 04, 2022
BUY
$92.03 - $107.81 $88,256 - $103,389
959 Added 19.55%
5,865 $603,000
Q2 2022

Jul 27, 2022
SELL
$75.79 - $100.07 $2.67 Million - $3.52 Million
-35,189 Reduced 87.76%
4,906 $482,000
Q1 2022

May 13, 2022
BUY
$72.45 - $94.81 $1.32 Million - $1.73 Million
18,222 Added 83.31%
40,095 $3.71 Million
Q4 2021

Feb 14, 2022
BUY
$79.65 - $106.22 $309,838 - $413,195
3,890 Added 21.63%
21,873 $1.85 Million
Q3 2021

Oct 29, 2021
SELL
$86.18 - $99.03 $119,445 - $137,255
-1,386 Reduced 7.16%
17,983 $1.72 Million
Q2 2021

Aug 06, 2021
BUY
$89.43 - $102.27 $301,736 - $345,058
3,374 Added 21.09%
19,369 $1.88 Million
Q1 2021

May 11, 2021
SELL
$87.57 - $119.4 $250,275 - $341,245
-2,858 Reduced 15.16%
15,995 $1.56 Million
Q4 2020

Feb 12, 2021
BUY
$86.91 - $108.33 $1.64 Million - $2.04 Million
18,853 New
18,853 $2.22 Million

Others Institutions Holding NBIX

# of Institutions
655
Shares Held
96.6M
Call Options Held
282K
Put Options Held
281K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $10.9B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Vontobel Holding Ltd. Portfolio

Follow Vontobel Holding Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Vontobel Holding Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email